November 15, 2011
November 15, 2011 — A clinical trial has shown a drug-eluting stent (DES) with a bioabsorbable polymer has comparable…
November 14, 2011
November 14, 2011 – Boston Scientific welcomed positive outcomes from the COBRA clinical trial, which evaluated post-…
November 14, 2011
November 14, 2011 – Medrad Inc. announced that five-year data from the THUNDER trial [1] demonstrated a 59 percent…
November 14, 2011
November 14, 2011 – OrbusNeich announced the introduction of the Combo dual therapy stent during a breakfast symposium…
November 14, 2011
November 14, 2011 — A clinical trial of patients with restenosis in drug-eluting stents (DES) in native coronary…
November 14, 2011
November 14, 2011 – The TWENTE clinical trial, which compared Resolute versus Xience V drug-eluting stents in a real-…
November 14, 2011
November 14, 2011 — Everist Genomics announced plans to commercialize its CardioDefender diagnostic system. It is the…
November 14, 2011
November 14, 2011 – The American Society of Echocardiography (ASE) reported that the Cardiovascular and Renal Drugs…
November 14, 2011
November 14, 2011 – ProTron Technologies announces a new approach to early detection of aneurysms in vascular systems…
November 14, 2011
November 14, 2011 — Edwards Lifesciences Corp. announced data were presented on the quality of life impact and cost…
November 11, 2011
November 11, 2011 — Maquet Cardiovascular announced U.S. Food and Drug Administration (FDA) 510(k) clearance and CE…
November 11, 2011
November 11, 2011 – Boston Scientific reported results from the EVOLVE first human use trial demonstrating the non-…
November 11, 2011
November 11, 2011 – Biosensors International Group announced two-year results from the BioFreedom first-in-human trial…
November 11, 2011
November 11, 2011 — The 30-day results from the 8,500+ patient ADAPT-DES registry were presented at the 2011 TCT…
November 10, 2011
MitraClip Offers Significant Improvements for Both Functional, Degenerative MR in High-Risk Patients
November 10, 2011 — The results of an analysis of 149 EVEREST II high surgical risk patients with significant mitral…
November 10, 2011
November 10, 2011 — Edwards Lifesciences Corp. announced the U.S. Food and Drug Administration (FDA) conditionally…
November 10, 2011
November 10, 2011 – GE Healthcare will feature several new products and solutions at the Cardiovascular Research…
November 10, 2011
November 9, 2011 — InfraReDx Inc. announced the launch of its TVC Imaging System, an enhanced version of the LipiScan…
November 09, 2011
November 9, 2011 — Currently under review by the U.S. Food and Drug Administration (FDA), the Resolute drug-eluting…
November 09, 2011
November 9, 2011 – AstraZeneca announced that a combined expert committee of American College of Cardiology Foundation…
